GPOH Konsortium Sichelzellkrankheit
Industry / private company
Location:
Köln,
Germany (DE)
ISNI: -
The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/β-thalassaemia and no or low HbA expression. (2024)
Weru V, Grosse R, Kopp-Schneider A, Kulozik AE, Lassay L, Kontny U, Frühwald M, et al.
Journal article
Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea (2022)
Allard P, Alhaj N, Lobitz S, Cario H, Jarisch A, Grosse R, Oevermann L, et al.
Journal article
Sickle cell disease in Germany: Results from a national registry (2019)
Kunz JB, Lobitz S, Grosse R, Oevermann L, Hakimeh D, Jarisch A, Cario H, et al.
Journal article